https://www.clinuvel.com/wp-content/uploads/2019/10/FDA-GRANTS-MARKETING-APPROVAL-FOR-SCENESSE%C2%AE.pdf
It would have been nice to be the first to be FDA approved in Australia, but this is another Australian company that has done so and look at their share price in the process.
The process took a decade (as it has with Mesoblast), but the fruits are there to be seen (albeit for a much smaller indication/market).
Imagine the path Mesoblast will take on approval of just 1 of the blockbuster markets (Covid/Back/Heart).
GVHD is a shoe in, but most will not buy in bulk until confirmation is received.
Once in a lifetime opportunity.
Cell Therapy News/Articles, page-4531
-
- There are more pages in this discussion • 13,788 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.40 |
Change
0.020(1.45%) |
Mkt cap ! $1.592B | |||
| Open | High | Low | Value | Volume |
| $1.40 | $1.41 | $1.38 | $1.920M | 1.374M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 85 | $1.40 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.40 | 75590 | 9 |
View Market Depth
| Last trade - 12.19pm 17/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |